Compare KLAR & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KLAR | INDV |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United Kingdom | United States |
| Employees | 2831 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.4B |
| IPO Year | N/A | 2014 |
| Metric | KLAR | INDV |
|---|---|---|
| Price | $17.62 | $38.09 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 1.6M |
| Earning Date | 05-14-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $28.56 | N/A |
| Revenue Next Year | $19.93 | N/A |
| P/E Ratio | ★ N/A | $55.77 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $12.06 | $13.45 |
| 52 Week High | $47.48 | $41.00 |
| Indicator | KLAR | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | 57.87 |
| Support Level | $12.77 | $35.36 |
| Resistance Level | $18.55 | $41.00 |
| Average True Range (ATR) | 0.91 | 1.35 |
| MACD | -0.10 | 0.10 |
| Stochastic Oscillator | 72.77 | 88.67 |
Klarna Group PLC is a technology-driven payments company, with operations spanning multiple countries. It connects consumers and merchants with comprehensive payment solutions and tailored advertising solutions, both online and offline. Its payment solutions provide consumers with more control and flexibility over their payments. It is a digital bank and flexible payments provider building the next-generation AI-powered commerce network.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).